INTERLEUKIN-22 SERUM LEVELS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN SANA'A CITY, YEMEN

  • Dekra A. EL-Aghbary Department of Medical Microbiology, Faculty of Medicine and Health Sciences, University of Sana'a, Yemen.
  • Safa'a M. Darwiesh Department of Medical Microbiology, Faculty of Medicine and Health Sciences, University of Sana'a, Yemen. https://orcid.org/0000-0001-9951-1254
  • Khaled A. Al-Moyed Department of Medical Microbiology, Faculty of Medicine and Health Sciences, University of Sana'a, Yemen. https://orcid.org/0000-0001-9109-963X

Abstract

Objective: Interleukin (IL) -22 is a novel mediator of a member of IL-10 family cytokines that is produced by many different types of lymphocytes including both those of innate and adaptive immune system. This cytokine has potent proliferative and inflammatory effects on different cell lines. Recently, accumulated data has indicated that IL-22 plays an important role in the pathogenesis of rheumatoid arthritis (RA). We aimed to investigate the levels of IL-22 and its association with demographic, clinical data as well as serological markers in RA.


Methods: IL-22 serum levels were measured in 45 newly diagnosed RA patients without any treatment and 45 healthy individuals as control by a manual Enzyme linked immunosorbent assay (ELISA). Correlations of IL-22 serum levels were sought with demographic, clinical data and serological parameters. IL-22 levels were significantly elevated in serum of RA patients (median= 86.89ng/ml and range = 896) compared to serum of healthy control (median=75.36ng/ml and range=459), p=.022.


Results: The IL-22 levels were correlated positively with C-reactive protein (CRP), anti-cyclic citrullinated peptide (ACCP) antibodies in RA patients. Significant higher levels of serum IL-22 in RA patients compare with those in healthy control.


Conclusion: Highly significant association between serum levels of IL-22 and the serological markers (CRP and ACCP antibodies) in the diagnosis of RA suggest the potential levels of IL-22 as a valuable biomarker for the evaluation of disease severity in RA patients.


Peer Review History:


Received 1 April 2018;   Revised 15 April; Accepted 6 May, Available online 15 May 2018


UJPR follows the most transparent and toughest ‘Advanced OPEN peer review’ system. The identity of the authors and, reviewers will be known to each other. This transparent process will help to eradicate any possible malicious/purposeful interference by any person (publishing staff, reviewer, editor, author, etc) during peer review. As a result of this unique system, all reviewers will get their due recognition and respect, once their names are published in the papers. We expect that, by publishing peer review reports with published papers, will be helpful to many authors for drafting their article according to the specifications. Auhors will remove any error of their article and they will improve their article(s) according to the previous reports displayed with published article(s). The main purpose of it is ‘to improve the quality of a candidate manuscript’. Our reviewers check the ‘strength and weakness of a manuscript honestly’. There will increase in the perfection, and transparency.


Received file


pdf3.JPG


Average Peer review marks at initial stage: 6.5/10


Average Peer review marks at publication stage: 8.0/10


Reviewer(s) detail:


Name: Dr. Hatem Sameir Abbas


Affiliation:


E-mail: hsam8406@yahoo.com


Comments of reviewer(s):


pdf3.JPG


Similar Articles:


THE ASSOCIATION BETWEEN LEVELS OF HEPCIDIN, IRON STATUS AND MICRO-INFLAMMATION MARKERS AMONG HAEMODIALYSIS


 

Keywords: Anti-cyclic citrullinated peptide antibody, C-reactive protein, Interleukin-22, rheumatoid arthritis, rheumatoid factor

Author Biographies

Dekra A. EL-Aghbary, Department of Medical Microbiology, Faculty of Medicine and Health Sciences, University of Sana'a, Yemen.

 

 

Safa'a M. Darwiesh, Department of Medical Microbiology, Faculty of Medicine and Health Sciences, University of Sana'a, Yemen.

 

 

Statistics
296 Views | 299 Downloads
How to Cite
EL-Aghbary, D. A., S. Darwiesh, and K. Al-Moyed. “INTERLEUKIN-22 SERUM LEVELS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN SANA’A CITY, YEMEN”. Universal Journal of Pharmaceutical Research, Vol. 3, no. 2, May 2018, pp. 6-11, doi:https://doi.org/10.22270/ujpr.v3i2.131.
Section
Research Articles